Daniel E. Weiner, MD, MS, FASN, Councilor
Current Position/Titles:
Degrees/Training:
ASN Service:
Member, American Society of Nephrology Dialysis Advisory Group, 2010-2013; Member, American Society of Nephrology ACO Task Force, Writing Group, 2011-2012; Member, American Society of Nephrology Quality & Safety Work Group, 2011-2012; Member, ASN Quality Metrics Task Force, 2012-2013; Chair, ASN Quality Metrics Task Force, 2013-2016; Member, ASN Public Policy Board, 2014-2016; ASN Representative, Kidney Care Partners, 2015-present; Member, ASN Policy and Advocacy Committee, 2016-present; Chair, ASN Quality Committee, 2016-2018; Member, ASN Quality Committee, 2019-present; Abstract Selection Committee Member, multiple years; Chair, Abstract Selection Committee for CKD Complications, 2012; Chair, Abstract Selection Committee for CKD: Cognition, Depression and Quality of Life, 2015.
Leadership positions:
Editor-in-Chief, Kidney Medicine, 2018-present; Deputy Editor, American Journal of Kidney Diseases, 2006-2016; Co-Editor-in-Chief, Primer on Kidney Diseases, 6th, 7th, and 8th editions; Medical Director of Clinical Research, Dialysis Clinic, Inc.; Chair, Tufts University School of Medicine Curriculum Committee, 2012-2015; Chair, Program Committee, 2016 National Kidney Foundation Spring Clinical Meetings, 2016; Member, National Kidney Foundation Scientific Advisory Board, 2021-present; Chair, ESRD Physician Level Measure Development Technical Expert Panel, 2018; Chair, NKF KDOQI Patient-Centered Quality Measures for Dialysis Care Workshop, 2022
Honors:
American Society of Nephrology Distinguished Leader Award, 2019; National Kidney Foundation J Michael Lazarus Award, 2022; Boston's Best Doctors, 2016-present
Board Certification:
ABIM Nephrology and Internal Medicine
Research Interests:
I have broad, collaborative research interests, all of which are inspired by the patients and families I work with every day. My focus areas include dialysis epidemiology, with extensive work on the impacts of COVID-19 on the dialysis community. Additionally, I am a principal investigator on a PCORI-funded study evaluation decision-making in older adults with advanced CKD. I am involved in clinical trials and have evaluated the intersection of CKD, cardiovascular disease, cerebrovascular disease and cognitive impairment. Lastly, I have published extensively on kidney policy, positioning me well to be a strong contributor to ASN Council.
Personal Statement:
I consider myself a clinician first, and everything else I do - in research, teaching or advocacy - is with the goal of helping the person in front of me or helping the next person confronting similar challenges. In 2016, I was thrilled to be selected as the inaugural chair of ASN's Quality Committee, and, in this role, I was privileged to work with exceptionally talented people to help conceptualize kidney policy. Moving forward, the kidney community faces many challenges including workforce issues, insufficient innovation, and inadequate research funding. As a member of ASN Council, I will continue my service to the kidney community, advocating vigorously to address these issues in order to improve care for all people with kidney disease and at risk for kidney diseases.